Skip to content

Médecine Générale JPX

Active
Private limited companyfounded 2024active for 2 yearsRoute Provinciale 51, 6567 Merbes-le-Château, BelgiumKBO/BCE: BE 1006.629.079
Summary

Médecine Générale JPX has been active since 2024 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €265,916 and a net result of €119,548. Its solvency ranks better than 71% of 20,736 sector peers (NACE 86, financial year 2025). The computed 12-month bankruptcy probability is below 0.1% (very low).

Overview

Official details

Source: KBO
Status
Active since 29-02-2024 Normal situation
Activity
General medical practice NACE 86210
Establishment unit
2.358.353.080 6567 Merbes-le-Château, since 01-03-2024
Financial year end
30 September
Peppol
Not found in the Peppol Directory

Board and ownership

Board
Shareholders
  • Jessica PAPLEUXdeed of 04-03-2024

Financial position

98 Excellent Checked score 2025
Bankruptcy probabilitywithin 12 months
< 0.1%
Annual accounts to 30-09-2025
Gross margin
€186,597
▼ 16.7%
Turnover
≈ €350,000
estimated
Profit
€119,548
▼ 16.6%
Equity
€265,916
▲ 81.7%
Total assets
€329,943
▲ 25.6%
Score breakdownlowers riskSector: Human health activities (NACE 86)Liquidity: current ratio 7.02, cash €126,699Equity €265,916 (80.6% of total assets)Figures for financial year 2025 (filed on 13-04-2026)Show the evidence

Checked score

Score 2025
98 / 100
Excellent
Probability in this band: under 0.55%
Financially stronger than 84% of micro companies in human health (NACE 86)
Financial strength · tick: 2024
Strong
Solvency 100+19
equity 80.6% of total assets
Liquidity 97+36
short-term debt 11.5% · cash 38.4%
Profitability 100=
return on assets 36.2%
Bankruptcy probability within 12 months
< 0.1% Very low
0%0.5%1.5%4%10%≥ 25%

Fewer than 1 in 1,000 comparable companies go bankrupt within 12 months (an estimate).

Sector median < 0.1% (24,173 companies, NACE 86, micro)
Last 24 months 03-2025: 0.3%highest value 04-2025: 0.3%● unchanged vs 03-2025highest value 05-2025: < 0.1%▼ -0.3 percentage points vs 04-2025 06-2025: < 0.1%● unchanged vs 05-2025 07-2025: < 0.1%● unchanged vs 06-2025 08-2025: < 0.1%● unchanged vs 07-2025 09-2025: < 0.1%● unchanged vs 08-2025 10-2025: < 0.1%● unchanged vs 09-2025 11-2025: < 0.1%● unchanged vs 10-2025 12-2025: < 0.1%● unchanged vs 11-2025 01-2026: < 0.1%● unchanged vs 12-2025 02-2026: < 0.1%● unchanged vs 01-2026 03-2026: < 0.1%● unchanged vs 02-2026 04-2026: < 0.1%● unchanged vs 03-2026 05-2026: < 0.1%● unchanged vs 04-2026lowest value 06-2026: < 0.1%● unchanged vs 05-2026lowest value 07-2026: < 0.1%● unchanged vs 06-2026lowest value 08-2026: < 0.1%● unchanged vs 07-2026lowest value 09-2026: < 0.1%● unchanged vs 08-2026lowest value 10-2026: < 0.1%● unchanged vs 09-2026lowest value 11-2026: < 0.1%● unchanged vs 10-2026lowest value
Credit of up to €25,000 on 30-day terms, only on tighter conditions: young company (under 3 years) without a track record
Liquidity is ample, with a current ratio of 7.02 (2.5 in 2024), above the usual 1.5. Short-term debt is 11.5% and cash 38.4% of total assets. 19.4% of the assets are financed with debt and provisions.
Calculation

The band follows from the bankruptcy probability. 10 more points roughly halve it.

75-100 Excellent under 0.55%
60-74 Healthy 0.55% to 1.5%
45-59 Fair 1.5% to 4.2%
25-44 Weak 4.2% to 15.0%
0-24 Critical over 15.0%

Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (NACE 86, micro). It does better than 82% of them on solvency, 85% on liquidity, 80% on profitability and 87% on growth.

The bankruptcy probability was computed on 04-11-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.

The probability rests on the annual accounts with balance sheet date 30-09-2025.

Of the companies with a bankruptcy probability in the very low class on 30-06-2025, 0.1% went bankrupt within twelve months.

Some facts cap the score, however low the probability. With negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late, the score is Fair at most (59). With two missing filings, it is Weak at most (44). During a judicial reorganisation or at the company's end (bankruptcy, dissolution, liquidation), it is Critical at most (24).

Credit check for an amount and term of your choice

Show the recommended maximum and see how the verdict changes with amount, term and advance.

The scores and ratios are Checked's own calculations, not a credit decision.

Signals

Six signals.
lowers riskraises riskneutral
lowers risk · Sector: Human health activities (NACE 86)
KBO
lowers risk · Liquidity: current ratio 7.02, cash €126,699
NBB · annual accounts
lowers risk · Equity €265,916 (80.6% of total assets)
NBB · annual accounts
lowers risk · Figures for financial year 2025 (filed on 13-04-2026)
NBB · annual accounts
raises risk · Young company
Founded in 2024, 2 years ago. Young companies fail more often than established ones; the risk is highest 2 to 8 years after founding.
KBO · incorporation date
Age against the risk zone
highest failure risk from 2 to 8 years 2 years 0 10 years
neutral · Latest accounts filed on time
The financial year that closed on 30-09-2025 was due by 30-04-2026 and was filed on 13-04-2026, 17 days ahead of the deadline.
NBB · 2 filings
Deviation from the deadline
2025
17 days early
2024
16 days early
← before the deadline after the deadline →
tick = median of all Belgian filingsring = median in the sector

The company filed its last 2 accounts on average 17 days before the deadline. In the sector (NACE 86), the median for financial year 2024 was 7 days before the deadline, and 36% of those companies filed late.

Searched, nothing found (2)
neutral · Next filing not due yet
The financial year that closed on 30-09-2026 is due by 30-04-2027. Nothing is late today.
Companies Code · seven months
Where today falls in the filing period
30-09-2026 year end05-11-2026 today30-04-2027 deadline
neutral · No strike-offs in the KBO publications
That holds for every publication since incorporation in 2024.
KBO publications

Key points

  • Positive: Equity rose in 2025from €146,367 to €265,916 ▲ 81.7% View

Recent changes

  1. · Gazette deed IncorporationFounding capital of €3,000, 100 shares · Founder: Jessica PAPLEUX · Appointment: Jessica PAPLEUX (director)
All 5 events

Comparable companies

These companies have the same main activity as Médecine Générale JPX: general medical practice (NACE 86210). They are comparable in size and age: total assets between €318,000 and €366,000, founded between 2023 and 2024.

CompanyTotal assetsGross margin
Médecine Générale JPX Merbes-le-Château€329,943€186,597
Dokter Amber Willemsen Dilbeek€318,200€188,585
Dr. Maarten Van Marcke Ghent€366,118€189,380
VanMedix Zoersel€339,438€184,211
Veerle Geeraerts Lommel€328,158€169,601
Karkide Tugba Huisarts Genk€360,960€182,084
Dr. Silke Viaene Hooglede€352,153€179,817
Full comparison

Key facts about Médecine Générale JPX

What is the company number of Médecine Générale JPX?
The company number of Médecine Générale JPX is 1006.629.079. The VAT number is the same number with BE in front: BE 1006.629.079.
Where is Médecine Générale JPX based?
The registered office is at Route Provinciale 51, 6567 Merbes-le-Château.Company details
What does Médecine Générale JPX do?
According to the KBO register, the main activity is general medical practice (NACE 86210).
What is the legal form of Médecine Générale JPX?
Médecine Générale JPX is a private limited company (BV).
When was Médecine Générale JPX founded?
Médecine Générale JPX was founded on 29-02-2024.
Is Médecine Générale JPX still active?
Yes, Médecine Générale JPX is an active enterprise in the KBO register.
What is the turnover of Médecine Générale JPX?
The turnover in financial year 2025 is ≈ €350,000. This figure is estimated from the gross margin of €186,597 and 30 comparable companies (NACE 86210). It probably lies between €270,000 and €420,000.Financials
Is Médecine Générale JPX profitable?
In financial year 2025, Médecine Générale JPX made a profit of €119,548.
Where can I find the annual accounts of Médecine Générale JPX?
Médecine Générale JPX filed 2 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
When are the next annual accounts of Médecine Générale JPX due?
Médecine Générale JPX must file the annual accounts for financial year 2026 by 30-04-2027.Timeline

Next steps

See how customers, suppliers and banks see your own company and what to improve first.

Keep this company with today's facts in a case file.